
Congress Stock Trades
Every stock trade members of the U.S. House disclose under the STOCK Act, parsed straight from the official Clerk filings. Free, no account needed.
- Trades filed · 30 days
- 319
- Members trading · 90 days
- 48
- Latest filing
- Sep 17, 2026
- Median disclosure delay
- 24 days
Money flow by ticker
Net sellingNet buyingLast 60 days · range midpoints- Nettradesmembers
Most active
Last 90 days
Gilbert Ray Cisneros, Jr.D85 Buy · 57 Sell143$2.3M
April McClain DelaneyD52 Buy · 87 Sell140$6.3M
Kevin HernR8 Buy · 36 Sell47$1.7M
Dan NewhouseR12 Buy · 19 Sell31$248K
David J. TaylorR17 Buy · 9 Sell26$233K
Richard McCormickR1 Buy · 25 Sell26$208K
Scott H. PetersD12 Buy · 10 Sell22$7.0M
Josh GottheimerD13 Buy · 7 Sell20$2.4M
Type
More filters
Party
Owner
Asset
Amount
Traded from
Traded to
Trades
Source: U.S. House Clerk periodic transaction reports| Member | Asset | Type | Owner | Filing | ||||
|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | Sell | Self | May 15, 2026 | Jun 8, 2026 | 24d | $1K – $15K | PDF ↗ | |
Julia LetlowRLA-5 | Regeneron Pharmaceuticals, Inc. | Buy | Self | Feb 12, 2026 | Mar 12, 2026 | 28d | $1K – $15K | PDF ↗ |
Regeneron Pharmaceuticals, Inc. | Buy | Self | Nov 18, 2025 | Dec 15, 2025 | 27d | $1K – $15K | PDF ↗ | |
Regeneron Pharmaceuticals, Inc. | Buy | Self | May 15, 2025 | Jun 9, 2025 | 25d | $1K – $15K | PDF ↗ | |
Byron DonaldsRFL-19 | Regeneron Pharmaceuticals, Inc. | Sell | Self | Apr 10, 2025 | May 24, 2025 | 44d | $1K – $15K | PDF ↗ |
Byron DonaldsRFL-19 | Regeneron Pharmaceuticals, Inc. | Sell | Spouse | Apr 10, 2025 | May 24, 2025 | 44d | $1K – $15K | PDF ↗ |
Julie JohnsonDTX-32 | Regeneron Pharmaceuticals, Inc. | Sell | Joint | Apr 1, 2025 | May 14, 2025 | 43d | $1K – $15K | PDF ↗ |
Regeneron Pharmaceuticals, Inc. | Sell | Self | Apr 8, 2025 | May 8, 2025 | 30d | $1K – $15K | PDF ↗ | |
Jefferson ShreveRIN-6 | Regeneron Pharmaceuticals, Inc. | Sell | Self | Apr 7, 2025 | May 8, 2025 | 31d | $15K – $50K | PDF ↗ |
Regeneron Pharmaceuticals, Inc. | Sell | Self | Feb 25, 2025 | Mar 27, 2025 | 30d | $1K – $15K | PDF ↗ | |
Julie JohnsonDTX-32 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Feb 12, 2025 | Mar 12, 2025 | 28d | $1K – $15K | PDF ↗ |
Julie JohnsonDTX-32 | Regeneron Pharmaceuticals, Inc. | Buy | Joint | Jan 15, 2025 | Feb 12, 2025 | 28d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Sell | Joint | Jan 24, 2025 | Feb 10, 2025 | 17d | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Regeneron Pharmaceuticals, Inc. | Sell | Joint | Nov 13, 2024 | Dec 12, 2024 | 29d | $15K – $50K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Nov 1, 2024 | Dec 12, 2024 | 41d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Nov 29, 2024 | Dec 5, 2024 | 6d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Nov 19, 2024 | Dec 5, 2024 | 16d | $1K – $15K | PDF ↗ |
Greg LandsmanDOH-1 | Regeneron Pharmaceuticals, Inc. | Sell | Spouse | Oct 15, 2024 | Nov 14, 2024 | 30d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Oct 23, 2024 | Nov 6, 2024 | 14d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Jul 1, 2024 | Aug 15, 2024 | 45d | $1K – $15K | PDF ↗ |
Greg LandsmanDOH-1 | Regeneron Pharmaceuticals, Inc. | Buy | Spouse | Aug 11, 2023 | Aug 14, 2024 | 369d ! | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Feb 8, 2024 | Mar 7, 2024 | 28d | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Regeneron Pharmaceuticals, Inc. | Buy | Joint | Jan 17, 2024 | Feb 15, 2024 | 29d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Nov 13, 2023 | Dec 8, 2023 | 25d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Buy | Joint | Aug 21, 2023 | Sep 16, 2023 | 26d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Buy | Joint | Jul 11, 2023 | Aug 21, 2023 | 41d | $1K – $15K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Jun 22, 2023 | Jul 11, 2023 | 19d | $1K – $15K | PDF ↗ |
Jonathan L. JacksonDIL-1 | Regeneron Pharmaceuticals, Inc. | Buy | Joint | Jun 23, 2023 | Jul 7, 2023 | 14d | $15K – $50K | PDF ↗ |
Josh GottheimerDNJ-5 | Regeneron Pharmaceuticals, Inc. | Partial sale | Joint | Mar 6, 2023 | Apr 20, 2023 | 45d | $1K – $15K | PDF ↗ |
How to read this data
- Members report dollar ranges, not exact amounts. Totals and flows use the midpoint of each range.
- The STOCK Act allows up to 45 days between a trade and its report. Delays past that are flagged with "!".
- Trades by a spouse or dependent child are included and labelled in the Owner column.
- Some filings exist only as scanned paper. Their trades are transcribed from the images and marked Scanned: they count in totals and flows, but not in performance scores.
- Handwritten paper filings cannot be read automatically and are not included yet. (241)
- Senate trades are not included yet.
- Public records shown for information only. Not investment advice.